One of the problems we have with Alz drugs is that we don't
One of the problems we have with Alz drugs is that we don't really know what the disease is. Sometimes people are diagnosed with Alzheimers and then it turns out that they have some other problem -- like thyroid, or tumor, or pressure on the brain which can be relieved with a stent.
There are various companies working on blood tests to try to diagnose Alzheimer's. Until there is a test that can detect it in living people, we're going to see drugs not appear to have the efficacy that they really do, because they're treating people for Alzheimer's when that person is suffering from some other syndrome.
So much we don't know, and so much time, money, and heartbreak wasted on the amyloid-theory drugs.
2
Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Market Sentiment for Exxon Mobil Corp Exxon Mobil Corp (NYSE:XOM) has recently witnessed a notable increase in its short interest as a percentage of float, which has surged by 3.37%. Current data indicates that there are approximately 39.97 million shares sold short, translating to 0.92% of all regular shares available for trading. With this trading volume,...
Continue Reading
Fresh Findings on Coveted Coastal Spots Here we are again with Travel And Tour World (TTW) rolling out their prized list of beachy paradises fit for 2026. They’ve done their homework and uncovered some of the finest spots our planet's surf and sand have to offer. This year, it's about much more than just pretty shores; it's an ode to pristine ecosystems and vibrant...
Continue Reading
Overview of FEMSA's Third Quarter 2024 Performance Fomento Económico Mexicano, S.A.B. de C.V. (NYSE: FMX) has recently shared its operational and financial results for the third quarter of 2024. The results display solid growth across various facets of the business, signaling resilience amidst a challenging economic landscape. Consolidated Revenue Growth The consolidated...
Continue Reading
Electro-Sensors, Inc. Financial Results for Q3 Electro-Sensors, Inc. (NASDAQ: ELSE), a prominent provider of machine monitoring sensors and hazard detection systems, reported impressive financial results for the third quarter. The company experienced a quarterly revenue of $2,512,000, marking a significant increase of 22.1% compared to the same period last year. Growth in...
Continue Reading
Global Net Lease, Inc. Reveals Preferred Stock Dividend Information Global Net Lease, Inc. (NYSE: GNL) has officially announced the declaration of quarterly dividends on its preferred stocks. This is a key development for the company as it continues to focus on providing value to its shareholders. The declared dividends are: Details of the Dividends The first dividend is...
Continue Reading